Natalie C. Holles - Net Worth and Insider Trading

Natalie C. Holles Net Worth

The estimated net worth of Natalie C. Holles is at least $14 Million dollars as of 2024-05-03. Natalie C. Holles is the CEO of Third Harmonic Bio Inc and owns about 1,218,836 shares of Third Harmonic Bio Inc (THRD) stock worth over $14 Million. Details can be seen in Natalie C. Holles's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Natalie C. Holles has not made any transactions after 2024-04-11 and currently still holds the listed stock(s).

Transaction Summary of Natalie C. Holles

To

Natalie C. Holles Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Natalie C. Holles owns 5 companies in total, including Rubius Therapeutics Inc (RUBY) , Audentes Therapeutics Inc (BOLD) , and Allakos Inc (ALLK) among others .

Click here to see the complete history of Natalie C. Holles’s form 4 insider trades.

Insider Ownership Summary of Natalie C. Holles

Ticker Comapny Transaction Date Type of Owner
RUBY Rubius Therapeutics Inc 2019-03-19 director
BOLD Audentes Therapeutics Inc 2020-01-15 President and COO
ALLK Allakos Inc 2020-12-21 director
2021-05-26 director
2024-04-11 director & CEO

Natalie C. Holles Latest Holdings Summary

Natalie C. Holles currently owns a total of 1 stock. Natalie C. Holles owns 1,218,836 shares of Third Harmonic Bio Inc (THRD) as of April 11, 2024, with a value of $14 Million.

Latest Holdings of Natalie C. Holles

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
THRD Third Harmonic Bio Inc 2024-04-11 1,218,836 11.66 14,205,534

Holding Weightings of Natalie C. Holles


Natalie C. Holles Form 4 Trading Tracker

According to the SEC Form 4 filings, Natalie C. Holles has made a total of 1 transactions in Third Harmonic Bio Inc (THRD) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Third Harmonic Bio Inc is the sale of 13,558 shares on April 11, 2024, which brought Natalie C. Holles around $165,272.

Insider Trading History of Natalie C. Holles

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Natalie C. Holles Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Natalie C. Holles Ownership Network

Ownership Network List of Natalie C. Holles

No Data

Ownership Network Relation of Natalie C. Holles


Natalie C. Holles Owned Company Details

What does Rubius Therapeutics Inc do?

Who are the key executives at Rubius Therapeutics Inc?

Natalie C. Holles is the director of Rubius Therapeutics Inc. Other key executives at Rubius Therapeutics Inc include CEO and President Dannielle Appelhans , director & Chief Executive Officer Pablo J Cagnoni , and Chief Scientific Officer Laurence A. Turka .

Rubius Therapeutics Inc (RUBY) Insider Trades Summary

Over the past 18 months, Natalie C. Holles made no insider transaction in Rubius Therapeutics Inc (RUBY). Other recent insider transactions involving Rubius Therapeutics Inc (RUBY) include a net sale of 15,688 shares made by Pablo J Cagnoni , a net sale of 14,263 shares made by Dannielle Appelhans , and a net sale of 2,593 shares made by Laurence A. Turka .

In summary, during the past 3 months, insiders sold 0 shares of Rubius Therapeutics Inc (RUBY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 32,544 shares of Rubius Therapeutics Inc (RUBY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 32,544 shares.

Rubius Therapeutics Inc (RUBY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Rubius Therapeutics Inc Insider Transactions

No Available Data

Natalie C. Holles Mailing Address

Above is the net worth, insider trading, and ownership report for Natalie C. Holles. You might contact Natalie C. Holles via mailing address: C/o Hyperion Therapeutics, Inc., 2000 Sierra Point Parkway, Suite 400, Brisbane Ca 94005.

Discussions on Natalie C. Holles

No discussions yet.